Christopher D. Ellis

1.9k citations

39 papers · 1.4k indexed · h-index 19

Health, Toxicology and Mutagenesis top 2%
Organic Chemistry top 10%
Global and Planetary Change top 10%
Molecular Biology
Sociology and Political Science top 10%

Co-authors: Byoung‐Suk Kweon Sang‐Woo Lee Daniel Schneider Kevin S. Cummings Junga Lee Sung‐Kwon Hong Mimi L. Quan Ruth R. Wexler
Topics: Urban Green Space and Health (8 papers)Blood Coagulation and Thrombosis Mechanisms (6 papers)Land Use and Ecosystem Services (6 papers)
Cited by: Health, Toxicology and Mutagenesis Transportation Speech and Hearing
Journals: Biophysical Journal Journal of Medicinal Chemistry Conservation Biology
Partner nations: United States South Korea Chile

In The Last Decade

Christopher D. Ellis

36 papers receiving 1.3k citations

Peers

Countries citing papers authored by Christopher D. Ellis

Since Specialization

Citations

This map shows the geographic impact of Christopher D. Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Ellis more than expected).

Fields of papers citing papers by Christopher D. Ellis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher D. Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Ellis. The network helps show where Christopher D. Ellis may publish in the future.

Co-authorship network of co-authors of Christopher D. Ellis

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher D. Ellis. A scholar is included among the top collaborators of Christopher D. Ellis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher D. Ellis. Christopher D. Ellis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Impact of a Mobile Laboratory on Water Quality Assessment in Remote Areas of Panama 2025 ·Sustainability ·(unknown),(unknown),(unknown),(unknown),Christopher D. Ellis,(unknown)	0
2	Exploring the Psychophysiological Effects of Viewing Urban Nature through Virtual Reality Using Electroencephalography and Perceived Restorativeness Scale Measures 2023 ·Sustainability ·(unknown),Byoung‐Suk Kweon,Christopher D. Ellis,Hyuk Oh,(unknown)	5
3	School Walk Zone: Identifying Environments That Foster Walking and Biking to School 2023 ·Sustainability ·Byoung‐Suk Kweon,(unknown),Christopher D. Ellis	4
4	The link between school environments and student academic performance 2017 ·Urban forestry & urban greening ·Byoung‐Suk Kweon,Christopher D. Ellis,Junga Lee,(unknown)	126
5	Deciphering the Glycosylation Code 2015 ·Biophysical Journal ·Christopher D. Ellis,(unknown)	2
6	The Role of Landscape Spatial Patterns on Obesity in Hispanic Children Residing in Inner-City Neighborhoods 2014 ·Journal of Physical Activity and Health ·Jun–Hyun Kim,Chanam Lee,(unknown),Christopher D. Ellis	32
7	Sidwell Friends Middle School 2012 ·Christopher D. Ellis,Byoung‐Suk Kweon,(unknown)	0
8	Design, structure–activity relationship, and pharmacokinetic profile of pyrazole-based indoline factor Xa inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey Varnes,Dean A. Wacker,(unknown),Mimi L. Quan,Christopher D. Ellis,Karen A. Rossi,(unknown),Joseph M. Luettgen,Robert M. Knabb,Steven Bai,Kan He,Patrick Y. S. Lam,Ruth R. Wexler	18
9	Synthesis and evaluation of unsaturated caprolactams as interleukin-1β converting enzyme (ICE) inhibitors 2006 ·Bioorganic & Medicinal Chemistry ·Yili Wang,Steven V. O’Neil,John A. Wos,(unknown),Michael C. Laufersweiler,(unknown),Christopher D. Ellis,(unknown),(unknown),Wei Lü,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	11
10	Synthesis and evaluation of novel 1-(2-acylhydrazinocarbonyl)-cycloalkyl carboxamides as interleukin-1β converting enzyme (ICE) inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),Steven V. O’Neil,Yili Wang,Michael C. Laufersweiler,(unknown),John A. Wos,Christopher D. Ellis,(unknown),Wei Lü,Maureen K. Suchanek,(unknown),Biswanath De,Thomas Demuth	4
11	Synthesis and evaluation of thiazepines as interleukin-1β converting enzyme (ICE) inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Christopher D. Ellis,(unknown),Michael C. Laufersweiler,Steven V. O’Neil,(unknown),Yili Wang,John A. Wos,(unknown),Wei Lü,Maureen K. Suchanek,(unknown),Biswanath De,Thomas Demuth	11
12	Synthesis and evaluation of tricyclic pyrrolopyrimidinones as dipeptide mimetics: Inhibition of interleukin-1β-converting enzyme 2005 ·Bioorganic & Medicinal Chemistry Letters ·Michael C. Laufersweiler,Yili Wang,(unknown),Maureen K. Suchanek,(unknown),Wei Lu,(unknown),(unknown),Christopher D. Ellis,(unknown),Steven V. O’Neil,John A. Wos,(unknown)	9
13	Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-f][1,2,4]triazine based VEGFR-2 kinase inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·R. M. Borzilleri,Zhen‐Wei Cai,Christopher D. Ellis,Joseph Fargnoli,Aberra Fura,(unknown),Bindu Goyal,John T. Hunt,Steven Mortillo,Ligang Qian,John S. Tokarski,Viral Vyas,Barri Wautlet,(unknown),Rajeev S. Bhide	24
14	Discovery of novel conformationally restricted diazocan peptidomimetics as inhibitors of interleukin-1β synthesis 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Christopher D. Ellis,Michael C. Laufersweiler,Steven V. O’Neil,Yili Wang,(unknown),(unknown),John A. Wos,Biswanath De,(unknown),(unknown),Wei Lü,Maureen K. Suchanek,(unknown),(unknown)	18
15	Large-Scale Environmental Knowledge 2005 ·Environment and Behavior ·Byoung‐Suk Kweon,Christopher D. Ellis,Sang‐Woo Lee,George O. Rogers	32
16	Design, Synthesis, and Evaluation of Orally Active 4-(2,4-Difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines as Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Inhibitors 2005 ·Journal of Medicinal Chemistry ·R. M. Borzilleri,Xiaoping Zheng,Ligang Qian,Christopher D. Ellis,Zhen‐Wei Cai,Barri Wautlet,(unknown),Robert Jeyaseelan,Daniel Kukral,Aberra Fura,Amrita V. Kamath,Viral Vyas,John S. Tokarski,Joel C. Barrish,John T. Hunt,Louis J. Lombardo,Joseph Fargnoli,Rajeev S. Bhide	49
17	Discovery of 1-(3‘-Aminobenzisoxazol-5‘-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2‘-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide Hydrochloride (Razaxaban), a Highly Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor 2004 ·Journal of Medicinal Chemistry ·Mimi L. Quan,Patrick Y. S. Lam,Qi Han,Donald Pinto,Ming He,Renhua Li,Christopher D. Ellis,Charles G. Clark,Christopher A. Teleha,Jung‐Hui Sun,Richard Alexander,Steve Bai,Joseph M. Luettgen,Robert M. Knabb,Pancras C. Wong,Ruth R. Wexler	147
18	Nonbenzamidine isoxazoline derivatives as factor Xa inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Mimi L. Quan,Christopher D. Ellis,(unknown),Ann Y. Liauw,Patrick Y. S. Lam,Karen A. Rossi,Robert M. Knabb,Joseph M. Luettgen,Matthew Wright,Pancras C. Wong,Ruth R. Wexler	17
19	WATER RESOURCE MANAGEMENT IN THE TEXAS MEGACITY: A PRIMA FACIE CASE FOR COMPREHENSIVE RESOURCE MANAGEMENT 2001 ·George O. Rogers,Christopher D. Ellis	2
20	Balanced AT1/AT2 Receptor Antagonists. 4. XR510 and Related 5-(3-Amidopropanoyl)imidazoles Possessing Equal Affinity for the AT1 and AT2 Receptors 1995 ·Journal of Medicinal Chemistry ·Mimi L. Quan,Andrew T. Chiu,Christopher D. Ellis,Pancras C. Wong,Ruth R. Wexler,Pieter B.M.W.M. Timmermans	13

About Christopher D. Ellis

Christopher D. Ellis is a scholar working on Health, Toxicology and Mutagenesis, Hematology and Global and Planetary Change, having authored 39 papers that have together received 1.4k indexed citations. Recurring topics across this work include Urban Green Space and Health (8 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Land Use and Ecosystem Services (6 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (391 citations), Transportation (117 citations) and Speech and Hearing (95 citations). Christopher D. Ellis has collaborated with scholars based in United States, South Korea and Chile. Frequent co-authors include Byoung‐Suk Kweon, Sang‐Woo Lee, Daniel Schneider, Kevin S. Cummings, Junga Lee, Sung‐Kwon Hong, Mimi L. Quan, Ruth R. Wexler, Pancras C. Wong and Robert M. Knabb. Their work appears in journals such as Biophysical Journal, Journal of Medicinal Chemistry and Conservation Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact